Elena Neumann

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Topics

Ankylosing Spondylitis

Prefrontal Cortex

Systemic Sclerosis

Top Venues

International journal of environmental research and public health

European journal of rheumatology

Advances in rheumatology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Ann-Kathrin Lederer, Maximilian Andreas Storz, Roman Huber, Luciana Hannibal, Elena Neumann
Plasma Leptin and Adiponectin after a 4-Week Vegan Diet: A Randomized-Controlled Pilot Trial in Healthy Participants. International journal of environmental research and public health 19 (18) (2022)
Elena Schwendich, Laura Salinas Tejedor, Gernot Schmitz, Markus Rickert, Juergen Steinmeyer, Stefan Rehart, Styliani Tsiami, Jürgen Braun, Xenofon Baraliakos, Jörg Reinders, Elena Neumann, Ulf Müller-Ladner, Silvia Capellino
Modulation of Dopamine Receptors on Osteoblasts as a Possible Therapeutic Strategy for Inducing Bone Formation in Arthritis. Cells 11 (10) (2022)
Miriam Thomalla, Andreas Schmid, Julia Hehner, Sebastian Koehler, Elena Neumann, Ulf Müller-Ladner, Andreas Schäffler, Thomas Karrasch
Toll-like Receptor 7 (TLR7) Is Expressed in Adipocytes and the Pharmacological TLR7 Agonist Imiquimod and Adipocyte-Derived Cell-Free Nucleic Acids (cfDNA) Regulate Adipocyte Function. International journal of molecular sciences 23 (15) (2022)
Philipp Klemm, Johanna Becker, Iris Aykara, Thomas Asendorf, Gabriel Dischereit, Elena Neumann, Ulf Müller-Ladner, Uwe Lange
Serial whole-body cryotherapy in fibromyalgia is effective and alters cytokine profiles. Advances in rheumatology (London, England) 61 (1) (2021)
Elena Neumann, Rebecca Hasseli, Selina Ohl, Uwe Lange, Klaus W Frommer, Ulf Müller-Ladner
Adipokines and Autoimmunity in Inflammatory Arthritis. Cells 10 (2) (2021)
Klaus W Frommer, Elena Neumann, Ulf Müller-Ladner
Role of adipokines in systemic sclerosis pathogenesis. European journal of rheumatology 7 (Suppl 3) (2020)